Crystal structure and catalytic performance of D-allulose 3-epimerase from Ruminococcus albus

A structural target for allulose enzymes

Enzyme suppliers keep looking for a better DAE. The latest structural work on an enzyme from Ruminococcus albus gives them a clearer target to engineer. That matters for allulose buyers, because the structure determines how the enzyme behaves under process conditions.

The background: D-allulose and DAE

D-allulose is a low-calorie rare sugar with applications in food, pharma, and other industries. Producing it at scale usually means enzymatic conversion. The enzyme class that makes this possible is D-allulose 3-epimerase, or DAE. Formulators care about three things in a DAE: conversion rate, cofactor requirements, and structural stability. This paper addresses the first two and adds a detailed structure to the mix.

What the study did

Researchers worked with DAE from Ruminococcus albus, a source that had not received the same attention as other DAE producers. They tested the enzyme at pH 7.5 in the presence of cobalt ions. Under those conditions, it achieved a 32.5% conversion rate.

Then they solved the crystal structure. The overall fold is highly similar to previously reported DAE structures. That may sound expected, but it is useful. Structural similarity gives researchers a molecular basis for engineering, because they can compare active-site architecture across related enzymes.

Key findings

Parameter	Finding
Enzyme source	Ruminococcus albus DAE
pH	7.5
Metal cofactor	Cobalt
Conversion rate	32.5%
Crystal structure	Solved; fold similar to known DAE enzymes
Upside	Provides a base for rational engineering

The 32.5% figure matters, but not because it is a commercial yield. It is a well-defined baseline. Process developers need baselines like this to measure improvement.

What it means for manufacturers

Buyers should not treat 32.5% as the final number for a commercial process. Think of it as a starting point. The enzyme runs under mild pH with a cobalt cofactor. That gives formulators a defined condition set to test.

The structural similarity to other DAE enzymes is the bigger story. When an enzyme shares the same overall fold as others in its family, engineering strategies from those other enzymes become more portable. Active-site mutations that improve activity in one DAE may transfer to this one. That shortens the development cycle.

For ingredient buyers, the practical translation is simple. Ask enzyme suppliers whether their product is based on a characterized DAE structure. If they say yes, they can explain which parts of the structure they modified, and why. If they cannot, the selling process is less transparent.

Questions you might ask

What does DAE do? DAE converts fructose into D-allulose. It is the enzyme workhorse behind enzyme-based allulose production.

Why does crystal structure matter for formulation? Structure gives you engineering targets. You can see where mutations might improve activity, thermostability, or cofactor preference. Without a structure, enzyme optimization relies on blind screening.

Can I use this enzyme today? This paper is structural characterization, not a product launch. It describes what the enzyme does and what it looks like. Commercial enzymes built from this scaffold may follow, but they are not in this paper.

The takeaway for allulose buyers

A structure alone does not make a commercial enzyme. But a structure with measured conversion data gives enzyme developers a concrete starting block. The Ruminococcus albus DAE now has that. Watch for variants built on this backbone, especially ones that improve on the 32.5% baseline. That is where the next useful DAE products will come from.